Your browser doesn't support javascript.
SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine.
Anderson, Mark; Stec, Michael; Rewane, Ayesan; Landay, Alan; Cloherty, Gavin; Moy, James.
  • Anderson M; Abbott Laboratories, Abbott Diagnostics Division, Abbott Park, Illinois.
  • Stec M; Abbott Laboratories, Abbott Diagnostics Division, Abbott Park, Illinois.
  • Rewane A; Division of Allergy and Immunology, Department of Internal Medicine, Rush University Medical Center, Rush University, Chicago, Illinois.
  • Landay A; Division of Allergy and Immunology, Department of Internal Medicine, Rush University Medical Center, Rush University, Chicago, Illinois.
  • Cloherty G; Abbott Laboratories, Abbott Diagnostics Division, Abbott Park, Illinois.
  • Moy J; Division of Allergy and Immunology, Department of Internal Medicine, Rush University Medical Center, Rush University, Chicago, Illinois.
JAMA Netw Open ; 4(8): e2119741, 2021 08 02.
Article in English | MEDLINE | ID: covidwho-1344954

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral / Antibody Formation Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: JAMA Netw Open Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral / Antibody Formation Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: JAMA Netw Open Year: 2021 Document Type: Article